These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


658 related items for PubMed ID: 29957468

  • 21. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.
    Cheng S, Zhang X, Xu Y, Dai X, Li J, Zhang T, Chen X.
    Sci Rep; 2018 Nov 27; 8(1):17415. PubMed ID: 30479372
    [Abstract] [Full Text] [Related]

  • 22. RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma.
    Han H, Yuan Y, Li C, Liu L, Yu H, Han G, Wang Q, Lin M, Huang J.
    Cancer Lett; 2024 Nov 01; 604():217191. PubMed ID: 39181434
    [Abstract] [Full Text] [Related]

  • 23. Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.
    Ku CY, Liu YH, Lin HY, Lu SC, Lin JY.
    Oncotarget; 2016 Apr 05; 7(14):18229-46. PubMed ID: 26919097
    [Abstract] [Full Text] [Related]

  • 24. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL, Huang Y, Li LF, Zhu HL, Gao HX, Liu H, Lv SQ, Xu ZH, Zheng LN, Liu T, Zhang JL, Jin HJ, Qian QJ.
    Acta Pharmacol Sin; 2015 Oct 05; 36(10):1237-45. PubMed ID: 25937637
    [Abstract] [Full Text] [Related]

  • 25. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H, Wang C, Jin G, Ruan H, Gu D, Wei L, Wang H, Wang N, Arunachalam E, Zhang Y, Deng X, Yang C, Xiong Y, Feng H, Yao M, Fang J, Gu J, Cong W, Qin W.
    Gastroenterology; 2017 Sep 05; 153(3):799-811.e33. PubMed ID: 28583823
    [Abstract] [Full Text] [Related]

  • 26. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
    Fu C, An N, Liu J, A J, Zhang B, Liu M, Zhang Z, Fu L, Tian X, Wang D, Dong JT.
    J Biol Chem; 2020 May 15; 295(20):7060-7074. PubMed ID: 32277050
    [Abstract] [Full Text] [Related]

  • 27. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
    Matsubara M, Shiraha H, Kataoka J, Iwamuro M, Horiguchi S, Nishina S, Takaoka N, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yamamoto K.
    J Gastroenterol Hepatol; 2012 Oct 15; 27(10):1602-8. PubMed ID: 22554292
    [Abstract] [Full Text] [Related]

  • 28. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
    Wang X, Dong J, Jia L, Zhao T, Lang M, Li Z, Lan C, Li X, Hao J, Wang H, Qin T, Huang C, Yang S, Yu M, Ren H.
    Cancer Lett; 2017 May 01; 393():113-124. PubMed ID: 28153790
    [Abstract] [Full Text] [Related]

  • 29. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
    Xing S, Zhang B, Hua R, Tai WC, Zeng Z, Xie B, Huang C, Xue J, Xiong S, Yang J, Liu S, Li H.
    BMC Cancer; 2015 May 07; 15():368. PubMed ID: 25947641
    [Abstract] [Full Text] [Related]

  • 30. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
    Chen H, Nio K, Tang H, Yamashita T, Okada H, Li Y, Doan PTB, Li R, Lv J, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S.
    Int J Mol Sci; 2022 Jan 27; 23(3):. PubMed ID: 35163396
    [Abstract] [Full Text] [Related]

  • 31. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
    Matsuura Y, Wada H, Eguchi H, Gotoh K, Kobayashi S, Kinoshita M, Kubo M, Hayashi K, Iwagami Y, Yamada D, Asaoka T, Noda T, Kawamoto K, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M.
    Dig Dis Sci; 2019 Mar 27; 64(3):792-802. PubMed ID: 30465177
    [Abstract] [Full Text] [Related]

  • 32. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
    Yan JJ, Zhang YN, Liao JZ, Ke KP, Chang Y, Li PY, Wang M, Lin JS, He XX.
    Oncotarget; 2015 Oct 06; 6(30):29527-42. PubMed ID: 26336827
    [Abstract] [Full Text] [Related]

  • 33. MicroRNA‑302a inhibits cell proliferation and invasion, and induces cell apoptosis in hepatocellular carcinoma by directly targeting VEGFA.
    Qin C, Zha W, Fan R, Ding H, Xu Y, Wang C.
    Mol Med Rep; 2017 Nov 06; 16(5):6360-6367. PubMed ID: 28849033
    [Abstract] [Full Text] [Related]

  • 34. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
    Liu P, Atkinson SJ, Akbareian SE, Zhou Z, Munsterberg A, Robinson SD, Bao Y.
    Sci Rep; 2017 Oct 04; 7(1):12651. PubMed ID: 28978924
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Serum fatty acid-binding protein 5 is a significant factor in hepatocellular carcinoma progression independent of tissue expression level.
    Ohira M, Yokoo H, Ogawa K, Fukai M, Kamiyama T, Sakamoto N, Taketomi A.
    Carcinogenesis; 2021 Jun 21; 42(6):794-803. PubMed ID: 33754641
    [Abstract] [Full Text] [Related]

  • 37. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
    Zhou Y, Li Y, Xu S, Lu J, Zhu Z, Chen S, Tan Y, He P, Xu J, Proud CG, Xie J, Shen K.
    Int J Cancer; 2020 Mar 01; 146(5):1383-1395. PubMed ID: 31286509
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
    Ding H, Zhang X, Su Y, Jia C, Dai C.
    Cell Mol Biol Lett; 2020 Mar 01; 25():8. PubMed ID: 32123532
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 33.